N-Cadherin 抗体
(Cadherin 2 (CDH2))
This gene is a classical cadherin from the cadherin superfamily. The encoded protein is a calcium dependent cell-cell adhesion glycoprotein comprised of five extracellular cadherin repeats, a transmembrane region and a highly conserved cytoplasmic tail. The protein functions during gastrulation and is required for establishment of left-right asymmetry. At certain central nervous system synapses, presynaptic to postsynaptic adhesion is mediated at least in part by this gene product. [provided by RefSeq, Jul 2008].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| N-Cadherin 抗体 (Middle Region) (Fluoro550) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| N-Cadherin 抗体 (AA 170-266) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| N-Cadherin 抗体 (Middle Region) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| N-Cadherin 抗体 (Middle Region) (APC) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| N-Cadherin 抗体 (AA 170-266) (APC) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| N-Cadherin 抗体 (Middle Region) (Cy3) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| N-Cadherin 抗体 (AA 170-266) (Cy3) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| N-Cadherin 抗体 (AA 170-266) (FITC) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| N-Cadherin 抗体 (Middle Region) (FITC) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| N-Cadherin 抗体 (Middle Region) (Fluoro488) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| N-Cadherin 抗体 (AA 170-266) (Fluoro488) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| N-Cadherin 抗体 (AA 170-266) (PE) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| N-Cadherin 抗体 (Middle Region) (PE) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| N-Cadherin 抗体 (Middle Region) (Fluoro647) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| N-Cadherin 抗体 (AA 170-266) (Fluoro647) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| N-Cadherin 抗体 (Cytoplasmic Domain) (CF®568) | 人, 小鼠 | 小鼠 Monoclonal |
|
|
|
| N-Cadherin 抗体 (Cytoplasmic Domain) (CF®594) | 人, 小鼠 | 小鼠 Monoclonal |
|
|
|
| N-Cadherin 抗体 (Cytoplasmic Domain) (CF®488A) | 人, 小鼠 | 小鼠 Monoclonal |
|
|
|
| N-Cadherin 抗体 (Cytoplasmic Domain) (Biotin) | 人, 小鼠 | 小鼠 Monoclonal |
|
|
|
| N-Cadherin 抗体 (Cytoplasmic Domain) (CF®640R) | 人, 小鼠 | 小鼠 Monoclonal |
|
|
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro550
- 抗体亚型
- IgG
- 抗原表位
- Middle Region
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- ELISA (ELISA: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 170-266
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 质量等级
- Carrier-free
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- Middle Region
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- APC
- 抗体亚型
- IgG
- 抗原表位
- Middle Region
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- ELISA (ELISA: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- APC
- 抗体亚型
- IgG
- 抗原表位
- AA 170-266
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy3
- 抗体亚型
- IgG
- 抗原表位
- Middle Region
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- ELISA (ELISA: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy3
- 抗体亚型
- IgG
- 抗原表位
- AA 170-266
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- ELISA (ELISA: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 170-266
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- Middle Region
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro488
- 抗体亚型
- IgG
- 抗原表位
- Middle Region
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- ELISA (ELISA: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro488
- 抗体亚型
- IgG
- 抗原表位
- AA 170-266
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- ELISA (ELISA: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- PE
- 抗体亚型
- IgG
- 抗原表位
- AA 170-266
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- PE
- 抗体亚型
- IgG
- 抗原表位
- Middle Region
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro647
- 抗体亚型
- IgG
- 抗原表位
- Middle Region
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- ELISA (ELISA: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro647
- 抗体亚型
- IgG
- 抗原表位
- AA 170-266
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (Immunofluorescence: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 13A9
- 标记
- CF®568
- 抗体亚型
- IgG1 kappa
- 抗原表位
- Cytoplasmic Domain
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (Immunofluorescence: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 13A9
- 标记
- CF®594
- 抗体亚型
- IgG1 kappa
- 抗原表位
- Cytoplasmic Domain
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (Immunofluorescence: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 13A9
- 标记
- CF®488A
- 抗体亚型
- IgG1 kappa
- 抗原表位
- Cytoplasmic Domain
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (Immunofluorescence: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 13A9
- 标记
- Biotin
- 抗体亚型
- IgG1 kappa
- 抗原表位
- Cytoplasmic Domain
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (Immunofluorescence: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 13A9
- 标记
- CF®640R
- 抗体亚型
- IgG1 kappa
- 抗原表位
- Cytoplasmic Domain
Latest Publications for our N-Cadherin 抗体
: "TFAP2A potentiates lung adenocarcinoma metastasis by a novel miR-16 family/TFAP2A/PSG9/TGF-β signaling pathway." in: Cell death & disease, Vol. 12, Issue 4, pp. 352, (2021) (PubMed).
: "Hypomethylation of GDNF family receptor alpha 1 promotes epithelial-mesenchymal transition and predicts metastasis of colorectal cancer." in: PLoS genetics, Vol. 16, Issue 11, pp. e1009159, (2021) (PubMed).
: "Biejiajian Pill Inhibits Carcinogenesis and Metastasis via the Akt/GSK-3β/Snail Signaling Pathway in Hepatocellular Carcinoma." in: Frontiers in pharmacology, Vol. 12, pp. 610158, (2021) (PubMed).
: "Carboxyl-terminal polypeptide fragment of MUC16 combing stathmin1 promotes gallbladder cancer cell migration and invasion." in: Medical oncology (Northwood, London, England), Vol. 37, Issue 12, pp. 114, (2021) (PubMed).
: "Bioinformatics analysis of LINC01554 and its co‑expressed genes in hepatocellular carcinoma." in: Oncology reports, Vol. 44, Issue 5, pp. 2185-2197, (2021) (PubMed).
: "CLDN6 promotes tumor progression through the YAP1-snail1 axis in gastric cancer." in: Cell death & disease, Vol. 10, Issue 12, pp. 949, (2020) (PubMed).
: "Circular RNA Circ-03955 Promotes Epithelial-Mesenchymal Transition in Osteosarcoma by Regulating miR-3662/Metadherin Pathway." in: Frontiers in oncology, Vol. 10, pp. 545460, (2020) (PubMed).
: "DKK2 Impairs Tumor Immunity Infiltration and Correlates with Poor Prognosis in Pancreatic Ductal Adenocarcinoma." in: Journal of immunology research, Vol. 2019, pp. 8656282, (2020) (PubMed).
: "The lncRNA MACC1-AS1 promotes gastric cancer cell metabolic plasticity via AMPK/Lin28 mediated mRNA stability of MACC1." in: Molecular cancer, Vol. 17, Issue 1, pp. 69, (2019) (PubMed).
: "The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis." in: Pharmacological research, Vol. 131, pp. 102-111, (2019) (PubMed).
: "Hypomethylation of GDNF family receptor alpha 1 promotes epithelial-mesenchymal transition and predicts metastasis of colorectal cancer." in: PLoS genetics, Vol. 16, Issue 11, pp. e1009159, (2021) (PubMed).
: "Biejiajian Pill Inhibits Carcinogenesis and Metastasis via the Akt/GSK-3β/Snail Signaling Pathway in Hepatocellular Carcinoma." in: Frontiers in pharmacology, Vol. 12, pp. 610158, (2021) (PubMed).
: "Carboxyl-terminal polypeptide fragment of MUC16 combing stathmin1 promotes gallbladder cancer cell migration and invasion." in: Medical oncology (Northwood, London, England), Vol. 37, Issue 12, pp. 114, (2021) (PubMed).
: "Bioinformatics analysis of LINC01554 and its co‑expressed genes in hepatocellular carcinoma." in: Oncology reports, Vol. 44, Issue 5, pp. 2185-2197, (2021) (PubMed).
: "CLDN6 promotes tumor progression through the YAP1-snail1 axis in gastric cancer." in: Cell death & disease, Vol. 10, Issue 12, pp. 949, (2020) (PubMed).
: "Circular RNA Circ-03955 Promotes Epithelial-Mesenchymal Transition in Osteosarcoma by Regulating miR-3662/Metadherin Pathway." in: Frontiers in oncology, Vol. 10, pp. 545460, (2020) (PubMed).
: "DKK2 Impairs Tumor Immunity Infiltration and Correlates with Poor Prognosis in Pancreatic Ductal Adenocarcinoma." in: Journal of immunology research, Vol. 2019, pp. 8656282, (2020) (PubMed).
: "The lncRNA MACC1-AS1 promotes gastric cancer cell metabolic plasticity via AMPK/Lin28 mediated mRNA stability of MACC1." in: Molecular cancer, Vol. 17, Issue 1, pp. 69, (2019) (PubMed).
: "The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis." in: Pharmacological research, Vol. 131, pp. 102-111, (2019) (PubMed).
Aliases for N-Cadherin 抗体
cadherin 2 (CDH2) 抗体cadherin 2 S homeolog (cdh2.S) 抗体
cadherin 2 (cdh2) 抗体
cadherin 2 (Cdh2) 抗体
cadherin 2, type 1, N-cadherin (neuronal) (cdh2) 抗体
cadherin 2, type 1, N-cadherin (neuronal) (CDH2) 抗体
cadherin-2 抗体
Cadherin-2 抗体
CD325 抗体
CDH2 抗体
CDHN 抗体
cdhn 抗体
CDw325 抗体
cdw325 抗体
glo 抗体
lyr 抗体
N-cadherin 抗体
NCAD 抗体
ncad 抗体
Ncad 抗体
pac 抗体
wu:fb47h04 抗体
您还需要查找其他产品吗？
- N-Acylsphingosine Amidohydrolase (Acid Ceramidase) 1 抗体
- N-Acetylneuraminate Pyruvate Lyase (Dihydrodipicolinate Synthase) 抗体
- MZT1 抗体
- MZB1 抗体
- MYT1L 抗体
- MYT1 抗体
- MYST3 抗体
- MYST2 抗体
- MYST1 抗体
- MYSM1 抗体
- Myristoylated Alanine-Rich Protein Kinase C Substrate 抗体
- MYRIP 抗体
- Myozenin 3 抗体
- Myozenin 1 抗体
- MYOZ2 抗体
- Myotubularin Related Protein 7 抗体
- Myotubularin Related Protein 6 抗体
- Myotubularin Related Protein 1 抗体
- Myotilin 抗体
- Myosin, Light Chain 12B, Regulatory 抗体
You are here:
